MOTION SICKNESS- dimenhydrinate tablet 
Target Corporation

----------

Target 44-198

Active ingredient (in each tablet)

Dimenhydrinate 50 mg

Purpose

Antiemetic

Uses

for prevention and treatment of these symptoms associated with motion sickness:

Warnings

Do not use

for children under 2 years of age unless directed by a doctor.

Ask a doctor before use if you have

  • a breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers.

When using this product

  • marked drowsiness may occur
  • avoid alcoholic beverages
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • use caution when driving a motor vehicle or operating machinery

If pregnant or breast-feeding,

ask a health professional before use. 

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. 

Directions

adults and children 12 years and over1 to 2 tablets every 4-6 hours; do not exceed 8 tablets in 24 hours, or as directed by a doctor
children 6 to under 12 years½ to 1 tablet every 6-8 hours; do not exceed 3 tablets in 24 hours, or as directed by a doctor
children 2 to under 6 years½ tablet every 6-8 hours; do not exceed 1½ tablets in 24 hours, or as directed by a doctor

Other information

Inactive ingredients

croscarmellose sodium, dibasic calcium phosphate dihydrate, magnesium stearate, microcrystalline cellulose, silicon dioxide, stearic acid

Questions or comments?

Call 1-800-910-6874

Principal Display Panel

Compare to active ingredient in Dramamine® Original Formula*

Motion Sickness Relief
Dimenhydrinate 50 mg/Antiemetic

up&up

• Helps prevent nausea, dizziness and vomiting
  from motion sickness
• For adults and children

Actual Size
24 Tablets

TAMPER EVIDENT: DO NOT USE
IF PACKAGE IS OPENED OR IF
BLISTER UNIT IS TORN,
BROKEN OR SHOWS ANY
SIGNS OF TAMPERING

*This product is not manufactured or distributed by
Medtech Products Inc., owner of the registered trademark
Dramamine® Original Formula. 50844      REV0518F19808

094 01 0726 R00 C-002262-01-034-0000
Distributed by Target Corporation
Minneapolis, MN 55403
TM & ©2024 Target Brands, Inc.
NDC 11673-198-08

Target 44-198

Target 44-198

MOTION SICKNESS 
dimenhydrinate tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:11673-198
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M, 8-CHLOROTHEOPHYLLINE - UNII:GE2UA340FM) DIMENHYDRINATE50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
ColorwhiteScore2 pieces
ShapeROUNDSize9mm
FlavorImprint Code 44;198
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:11673-198-022 in 1 CARTON12/01/1992
16 in 1 BLISTER PACK; Type 0: Not a Combination Product
2NDC:11673-198-084 in 1 CARTON12/01/1992
26 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00912/01/1992
Labeler - Target Corporation (006961700)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464pack(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867837manufacture(11673-198) , pack(11673-198)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.117025878manufacture(11673-198)

Revised: 3/2024
Document Id: 9995dbb3-086d-47ca-9cc0-c596b7315b7f
Set id: 3fd4a96f-8f69-42bf-b777-6e3a2bfea275
Version: 15
Effective Time: 20240312
 
Target Corporation